Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Outcomes Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$4M
Portfolio companies 6
Lead investments 0
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Information Technology
  • Artificial Intelligence
  • Therapeutics
  • Pharmaceutical
  • Biotechnology

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Outcomes Fund:
Typical Co-investors
Outcomes Fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Outcomes Fund:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bowater Greenville, South Carolina, United States
Growth and Transition Capital -
Grupo Genetrix Community of Madrid, Madrid, Spain
Kyushu Electric Power Fukuoka, Fukuoka Prefecture, Japan
Leapfrog Ventures California, Menlo Park, United States
Novalia Cambridge, Cambridgeshire, United Kingdom
Polybius Capital Australia, New South Wales, Sydney
Tribune Publishing Chicago, Illinois, United States
Visual China Group Beijing, Beijing, China
Zhuhai Huaying China, Guangdong, Zhuhai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Phaidra

Artificial Intelligence
Industrial Automation
Information Technology
Machine Learning
$4M24 May 2021 Seattle, Washington, United States

Neyborly

Commercial Real Estate
Events
Marketplace
Real Estate
Retail
$3M10 Nov 2020 Oakland, California, United States

nFlux AI

Artificial Intelligence
Computer Vision
Consumer Research
Product Research
$3M31 Jul 2020 Los Angeles, California, United States

Athira Pharma

Biotechnology
Pharmaceutical
Therapeutics
$15M02 Nov 2017 Seattle, Washington, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Outcomes Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 4M
Peak activity year 2020
Lead investments 0
Exits 1
Group Appearance index 0.83

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Phaidra

Artificial Intelligence
Industrial Automation
Information Technology
Machine Learning
$4M24 May 2021 Seattle, Washington, United States

Neyborly

Commercial Real Estate
Events
Marketplace
Real Estate
Retail
$3M10 Nov 2020 Oakland, California, United States

nFlux AI

Artificial Intelligence
Computer Vision
Consumer Research
Product Research
$3M31 Jul 2020 Los Angeles, California, United States

Athira Pharma

Biotechnology
Pharmaceutical
Therapeutics
$15M02 Nov 2017 Seattle, Washington, United States
Crunchbase icon

Content report

The following text will be sent to our editors: